GenapSys Funds Its Sequencer Amid Fight Against The Coronavirus

Sequencing technology company, GenapSys has announced its raised $75 million from Oxford Financing. This comes just months after a Series C funding round which saw the California- based firm raise $90 million. It all comes down to the commercialization and distribution of the company's GenapSys Sequencer across the Asia Pacific region, including China which is at the center of the deadly Coronavirus outbreak...